Back
Calidi Biotherapeutics Stock Price Chart
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
4
CLDI
Calidi Biotherapeutics
Last Price:
$1.44
Seasonality Move:
-22.96%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLDI is experiencing buying pressure, which is a positive indicator for future bullish movement.
Calidi Biotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.61 | Sell |
| 20-day SMA: | 1.86 | Sell |
| 50-day SMA: | 1.68 | Sell |
| 200-day SMA: | 2.19 | Sell |
| 8-day EMA: | 1.57 | Sell |
| 20-day EMA: | 1.75 | Sell |
| 50-day EMA: | 1.71 | Sell |
| 200-day EMA: | 7.04 | Sell |
Calidi Biotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 37.69 | Sell |
| Chaikin Money Flow: | 432484 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.66 - 2.22) | Sell |
| Bollinger Bands (100): | (1.03 - 1.91) | Sell |
Calidi Biotherapeutics Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Calidi Biotherapeutics Stock
Is Calidi Biotherapeutics Stock a Buy?
-
Calidi Biotherapeutics share price is 1.41 while CLDI 8-day simple moving average is 1.61, which is a Sell signal.
-
The stock price of CLDI is 1.41 while Calidi Biotherapeutics 20-day SMA is 1.86, which makes it a Sell.
-
Calidi Biotherapeutics 50-day simple moving average is 1.68 while CLDI share price is 1.41, making it a Sell technically.
-
CLDI stock price is 1.41 and Calidi Biotherapeutics 200-day simple moving average is 2.19, creating a Sell signal.
CLDI Technical Analysis vs Fundamental Analysis
Sell
4
Calidi Biotherapeutics (CLDI)
is a Sell
Is Calidi Biotherapeutics a Buy or a Sell?
-
Calidi Biotherapeutics stock is rated a SellThe current Calidi Biotherapeutics [CLDI] share price is $1.41. The Score for CLDI is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
Calidi Biotherapeutics Stock Info
Market Cap:
24.7M
Price in USD:
1.41
Share Volume:
432.5K
Calidi Biotherapeutics 52-Week Range
52-Week High:
18.10
52-Week Low:
0.73
Sell
4
Calidi Biotherapeutics (CLDI)
is a Sell
Calidi Biotherapeutics Share Price Forecast
-
What is the Calidi Biotherapeutics stock price today?The Calidi Biotherapeutics stock price is 1.41 USD today.
-
Will CLDI stock go up or go down?Calidi Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Calidi Biotherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Calidi Biotherapeutics is overvalued.
Is Calidi Biotherapeutics Stock a Buy?
-
Calidi Biotherapeutics share price is 1.41 while CLDI 8-day exponential moving average is 1.57, which is a Sell signal.
-
The stock price of CLDI is 1.41 while Calidi Biotherapeutics 20-day EMA is 1.75, which makes it a Sell.
-
Calidi Biotherapeutics 50-day exponential moving average is 1.71 while CLDI share price is 1.41, making it a Sell technically.
-
CLDI stock price is 1.41 and Calidi Biotherapeutics 200-day simple moving average is 7.04, creating a Sell signal.
Fundamental Analysis of Calidi Biotherapeutics
Is Calidi Biotherapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.72 per share, and an increase next year of $0.29 per share.
Technical Analysis of Calidi Biotherapeutics
Should I short Calidi Biotherapeutics stock?
-
CLDI Moving Average Covergence Divergence (MACD) indicator is -0.1, suggesting Calidi Biotherapeutics is a Sell
-
Calidi Biotherapeutics Relative Strength Index (RSI) is 37.69, which suggest Calidi Biotherapeutics is oversold
-
The Bollinger Bands (25) for Calidi Biotherapeutics is (1.66 - 2.22), which suggest Calidi Biotherapeutics is a Sell
-
The Bollinger Bands (100) for Calidi Biotherapeutics is (1.03 - 1.91), which suggest Calidi Biotherapeutics is a Sell
* Calidi Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.